A new tick-borne virus linked to fever and stomach symptoms has been identified in China’s Hubei province, the same province where COVID-19 first emerged.
Story Snapshot
- Researchers reported a new virus, ALTNV, in patients with fever after tick bites.
- Testing found hundreds of cases across a large patient group in multiple provinces.
- The virus appears tied to the Asian longhorned tick, found in many regions.
- Illness looks like the flu, and coinfection may worsen symptoms.
What Scientists Found In Hubei And Beyond
Chinese researchers described a novel orthonairovirus, named Asian longhorned tick nairovirus, or ALTNV, in a letter published by The New England Journal of Medicine. The team linked the virus to people with fever and recent tick bites in Hubei and other provinces. Patients commonly had fever, fatigue, and stomach or gut issues, along with abnormal lab tests that signal infection or inflammation. Reporting on the study says ALTNV was detected in multiple regions, not just one hotspot, suggesting wider circulation.
Coverage of the paper says the researchers screened 3,163 patients who had fevers after tick bites across four provinces and found 329 ALTNV-positive cases, or about ten percent. That approach focuses on people with symptoms and a clear exposure, which helps spot a signal early. But it does not measure how common the virus is in the general public. The same reporting notes that coinfection with Dabie bandavirus may make illness worse.
The Tick Vector And Why It Matters
The study and summaries point to the Asian longhorned tick, called Haemaphysalis longicornis, as a likely vector for ALTNV. Surveys reportedly found virus-positive ticks across 15 provinces, showing a broad habitat range for the tick and the virus. The Asian longhorned tick is already known to carry other pathogens and has spread quickly in parts of Asia and beyond, which supports the case for close watch and better tick control. Prior work documents its rapid expansion and role in moving pathogens across regions.
Public health agencies and labs often treat new tick-borne orthonairoviruses with caution until follow-up data arrive. That is standard for this virus family, which includes both well-known threats and many new or poorly understood viruses. Recent research on other orthonairoviruses, like the Yezo virus, shows a pattern: first detection in sick patients and local ticks, then more studies to confirm cause, map spread, and define risk. This playbook helps prevent panic while speeding up tests, treatment research, and field surveillance.
What This Means For Risk And Preparedness
Based on the current reports, ALTNV appears to cause a flu-like illness in some people after tick bites. The documented symptoms are unpleasant but not described as fatal in the summaries we have. The study authors and outside experts will now need to run stronger tests to prove cause, measure how often severe disease happens, and learn if the virus lingers or clears fast. Officials also need data on hospitalizations, deaths, and long-term effects, which are not yet reported.
Researchers in China have identified a previously unknown tick-borne orthonairovirus in patients who looked as if they had severe fever with thrombocytopenia syndrome but tested negative for Dabie bandavirus.
The letter in the New England Journal of Medicine names the virus… pic.twitter.com/1JdUBUczt7
— Massimo (@Rainmaker1973) September 8, 2026
For families and outdoor workers, the advice stays simple and familiar: avoid ticks, wear long sleeves and pants, use insect repellent, and check your body and pets after time in grass or woods. For policymakers, this is a reminder that nature keeps moving while governments argue. Early detection and steady, transparent communication build trust. When agencies share methods, data, and limits clearly, people can act early instead of waiting for a crisis that costs more in money and lives.
The Bigger Picture: Science, Trust, And The Public
Many Americans on the left and right feel the system reacts late and spends big only after damage is done. A clear, peer-reviewed signal like this one is a chance to do better. Universities and health agencies can fund quick follow-up studies, share findings across borders, and prepare simple tests hospitals can use. That is how we avoid fear, fight rumor, and keep everyday life moving when a new microbe shows up in the headlines.
Sources:
insiderpaper.com, cidrap.umn.edu, pmc.ncbi.nlm.nih.gov, uaex.uada.edu, publichealthontario.ca
